Gestalt Diagnostics is a Spokane-based company dedicated to revolutionizing pathology through digital solutions. Founded in 2017, Gestalt provides advanced technology, proven digital expertise, and artificial intelligence to enable pathologists to diagnose diseases faster and more efficiently. The company's PathFlow platform is at the forefront of digital pathology innovation, offering significant improvements in diagnostic accuracy and workflow efficiency.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/28/25 | $7,500,000 | Series A |
Cowles Company Inland Imaging Investments Kickstart Seed Fund TVF Funds | undisclosed |
